|
Market Closed -
London S.E.
11:35:04 2025-07-24 EDT
|
5-day change | 1st Jan Change | ||
| 1,238.00 GBX | +1.56% |
|
+5.27% | +20.90% |
| 08-03 | Indivior Pharmaceuticals, Inc. Enters into Senior Secured Term Loan Facility | CI |
| 08-03 | Indivior Pharmaceuticals, Inc. Proposes Special Cash Dividend | CI |
Upcoming events on Indivior Pharmaceuticals, Inc.
No events available
Past events on Indivior Pharmaceuticals, Inc.
| 2026-08-04 | Earnings release - Q2 2026 | |
| 2026-05-13 | Présentation aux Actionnaires / Analystes | 10:00 |
| 2026-05-13 | Annual General Meeting | 10:00 |
| 2026-04-30 | Earnings presentation | 08:00 |
| 2026-04-30 | Earnings release - Q1 2026 | 07:00 |
| 2026-02-26 | Earnings presentation | 08:00 |
| 2026-02-26 | Earnings release - Q4 2025 | 07:00 |
| 2025-12-10 | Extraordinary General Meeting | |
| 2025-10-30 | Earnings presentation | 08:00 |
| 2025-10-30 | Earnings release - Q3 2025 | 07:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 093 1 077 1.45% | 1 188 1 152 3.15% | 1 239 1 191 4.03% | 1 332 | 1 400 | 1 489 |
|
EBITDA Million USD | Released Forecast Spread | 288 273 5.57% | 338 315 7.41% | 428 415 3.09% | 728 | 791 | 860 |
|
EBIT Million USD | Released Forecast Spread | 269 249 7.86% | 312 288 8.5% | 415 396 4.69% | 689 | 738 | 796 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1,00 88,3 -98.87% | -43,0 141 -130.4% | 262 292 -10.35% | 599 | 654 | 716 |
|
Net income Million USD | Released Forecast Spread | 2,00 34,6 -94.22% | -48,0 69,6 -168.99% | 210 225 -6.48% | 474 | 530 | 583 |
|
EPS USD | Released Forecast Spread | 0,01 0,24 -95.79% | -0,36 0,73 -149.09% | 1,64 1,76 -6.82% | 3,72 | 4,11 | 4,49 |
| Announcement Date | 22/02/24 | 20/02/25 | 26/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 | 2028 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 298 259 14.92% | 266 240 10.77% | 302 242 24.97% | 314 262 19.89% | 358 306 17.14% | 317 273 16.19% | 343 308 11.53% | 329 | 338 | 328 | 349 | 360 | 376 | 354 | 378 |
|
EBITDA Million USD | Released Forecast Spread | 120 75,0 60% | 164 115 42.98% | 186 162 15.17% | ||||||||||||
|
EBIT Million USD | Released Forecast Spread | 66,0 47,6 38.66% | 69,0 44,9 53.67% | 77,0 47,5 62.22% | 118 66,2 78.38% | 138 119 15.94% | 137 113 21.24% | 184 148 24.07% | 168 | 184 | 156 | 178 | 205 | 217 | 171 | 195 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 31,0 36,7 -15.42% | 59,0 37,2 58.82% | 62,0 36,5 70.1% | 37,0 37,0 0% | 81,0 87,8 -7.69% | 115 97,6 17.89% | 160 126 26.58% | 154 | 170 | 141 | 163 | 190 | 202 | 161 | 185 |
|
Net income Million USD | Released Forecast Spread | 9,00 28,1 -67.91% | 47,0 27,8 69.37% | 18,0 28,0 -35.71% | 42,0 29,4 43.1% | 102 67,1 52.13% | 89,0 79,0 12.66% | 122 99,8 22.24% | 122 | 134 | 110 | 127 | 148 | 158 | 125 | 144 |
|
EPS USD | Released Forecast Spread | 0,07 0,22 -67.44% | 0,38 0,22 76.74% | 0,14 0,22 -36.36% | 0,33 0,23 43.48% | 0,79 0,52 53.4% | 0,69 0,61 14.05% | 0,98 0,78 26.45% | 0,98 | 1,08 | 0,89 | 1,02 | 1,19 | 1,27 | 1,01 | 1,16 |
| Announcement Date | 20/02/25 | 24/04/25 | 31/07/25 | 30/10/25 | 26/02/26 | 30/04/26 | 03/08/26 | - | - | - | - | - | - | - | - |
| 2026-08-26 | Earnings release - Q2 2026 | ||
| Today | Earnings release - Q2 2026 | ||
| Today | Earnings release - Q2 2026 | ||
| Today | Earnings release - Q2 2026 | ||
| Today | Earnings release - Q2 2026 | ||
| Today | Earnings release - Q2 2026 | ||
| Today | Earnings release - Q2 2026 | ||
| 2026-08-26 | Information meeting | 23:30 | |
| 2026-08-26 | Information meeting | 21:00 | |
| Today | Earnings release - Q2 2026 |
Past sector events for Indivior Pharmaceuticals, Inc.
| Today | Earnings release - Q2 2026 | ||
| Today | Earnings release - Q2 2026 | ||
| Today | Earnings release - Q2 2026 | ||
| Today | Information meeting | 00:00 | |
| Today | Annual General Meeting | 01:30 | |
| Today | Présentation aux Actionnaires / Analystes | 01:30 | |
| Today | Ex-dividend date - 0.85 THB | 00:00 | |
| Today | Earnings release - Q2 2026 | ||
| Today | Earnings release - Q2 2026 | ||
| 2026-08-25 | Ex-dividend date - 1.34 USD | 00:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
- INDV Stock
- Calendar Indivior Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
















